SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-17-341047
Filing Date
2017-11-13
Accepted
2017-11-13 16:56:54
Documents
8

Document Format Files

Seq Description Document Type Size
1 424B5 d492419d424b5.htm 424B5 620201
2 GRAPHIC g492419g09t98.jpg GRAPHIC 87579
3 GRAPHIC g492419g15a09.jpg GRAPHIC 23181
4 GRAPHIC g492419g31u05.jpg GRAPHIC 46685
5 GRAPHIC g492419g33q34.jpg GRAPHIC 31748
6 GRAPHIC g492419g70k55.jpg GRAPHIC 70838
7 GRAPHIC g492419g80g84.jpg GRAPHIC 48247
8 GRAPHIC g492419g86z17.jpg GRAPHIC 96301
  Complete submission text file 0001193125-17-341047.txt   1178998
Mailing Address DARWINWEG 24 LEIDEN P7 2333CR
Business Address DARWINWEG 24 LEIDEN P7 2333CR 31(0)88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-207245 | Film No.: 171196767
SIC: 2834 Pharmaceutical Preparations